New surgery comparison aims to reduce bleeding in dangerous placenta condition

NCT ID NCT07520201

First seen Jun 27, 2026 · Last updated Jul 01, 2026 · Updated 2 times

Summary

This study compares three surgical techniques for managing placenta accreta, a condition where the placenta grows too deeply into the uterine wall. The goal is to find which method causes the least blood loss during delivery. The trial will enroll 42 pregnant women with this condition and measure outcomes like blood loss and complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

surgical procedure

What this could lead to

If successful, this could identify a safer surgical approach for placenta accreta, reducing severe bleeding and complications during delivery.

What could go wrong

This is a small, early-stage trial with only 42 participants, so results may not apply to all patients. All surgeries carry risks like infection or heavy bleeding.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PLACENTA ACCRETA SPECTRUM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

placenta accreta

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Women's Health Hospital

    RECRUITING

    Asyut, Egypt

    Contact Phone: •••-•••-•••• Email: •••••@•••••